Helen M. Thackray
2018 - GlycoMimetics
In 2018, Helen M. Thackray earned a total compensation of $1.6M as Chief Medical Officer at GlycoMimetics, a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $163,085 |
|---|---|
| Option Awards | $1,007,250 |
| Salary | $424,700 |
| Other | $5,447 |
| Total | $1,600,482 |
Thackray received $1M in option awards, accounting for 63% of the total pay in 2018.
Thackray also received $163.1K in non-equity incentive plan, $424.7K in salary and $5.4K in other compensation.
Rankings
In 2018, Helen M. Thackray's compensation ranked 6,859th out of 14,244 executives tracked by ExecPay. In other words, Thackray earned more than 51.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,859 out of 14,244 | 52nd |
Division Manufacturing | 2,629 out of 5,765 | 54th |
Major group Chemicals And Allied Products | 992 out of 2,128 | 53rd |
Industry group Drugs | 833 out of 1,817 | 54th |
Industry Pharmaceutical Preparations | 651 out of 1,391 | 53rd |
Source: SEC filing on April 10, 2019.
Thackray's colleagues
We found three more compensation records of executives who worked with Helen M. Thackray at GlycoMimetics in 2018.